Association of elevated levels of C-reactive protein with breast cancer, breast cancer subtypes, and poor outcome

Cancer statistics, 2015

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2015 · 11.9K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

Richard S. Finn, John Crown, István Láng et al. · The Lancet Oncology · 2014 · 1.9K citations

Medicine, Oncology, Pharmacology +17

Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients

Brandon L. Pierce, Rachel Ballard‐Barbash, Leslie Bernstein et al. · Journal of Clinical Oncology · 2009 · 690 citations · Full text

Medicine, Biostatistics, Oncology +17

Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores

Paul M. Ridker, Nancy R. Cook · Circulation · 2004 · 514 citations

Medicine, Cardiology, Clinical Epidemiology +15

Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer

Kristine H. Allin, Stig E. Bojesen, Børge G. Nordestgaard · Journal of Clinical Oncology · 2009 · 423 citations · Full text

Medicine, Oncology, Cancer Epidemiology +13